Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04242498 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa (BE HEARD II) |
| First Submitted : | January 23, 2020 |
| First Submitted that Met QC Criteria : | January 23, 2020 |
| First Posted : | January 27, 2020 |
| Certification/Extension First Submitted : | November 8, 2022 |
| Certification/Extension First Submitted that Met QC Criteria : | November 8, 2022 |
| Certification/Extension First Posted : | November 10, 2022 |
| Last Update Submitted that Met QC Criteria : | October 16, 2023 |
| Last Update Posted : | October 17, 2023 |